Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · IEX Real-Time Price · USD
1.930
-0.020 (-1.03%)
At close: Jul 19, 2024, 4:00 PM
1.950
+0.020 (1.04%)
Pre-market: Jul 22, 2024, 7:31 AM EDT
Tempest Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for TPST stock have an average target of 20.75, with a low estimate of 8.00 and a high estimate of 47. The average target predicts an increase of 975.13% from the current stock price of 1.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 21, 2024.
Analyst Ratings
The average analyst rating for TPST stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
Buy | 1 | 2 | 2 | 1 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 5 | 5 | 3 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +314.51% | Jun 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +2,335.23% | Jun 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +2,335.23% | May 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +2,335.23% | May 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +2,335.23% | Mar 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.55
from -1.91
EPS Next Year
-1.55
from -1.55
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 121.4M | 49.2M |
Avg | n/a | n/a | n/a | 23.6M | 21.7M |
Low | n/a | n/a | n/a | n/a | 3.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 108.8% |
Avg | - | - | - | - | -7.8% |
Low | - | - | - | - | -84.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.56 | -1.22 | -1.41 | -1.07 | -0.82 |
Avg | -1.55 | -1.55 | -1.37 | -2.50 | -1.74 |
Low | -1.51 | -1.84 | -1.31 | -4.05 | -3.09 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.